184 related articles for article (PubMed ID: 2220296)
1. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents.
Foss NT; Pagnano PM; Bechelli LM; Simoes AL
Acta Leprol; 1990; 7(2):119-28. PubMed ID: 2220296
[TBL] [Abstract][Full Text] [Related]
2. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs.
Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC
Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443
[TBL] [Abstract][Full Text] [Related]
3. The post-lepromin scar and its significance in the control of HD.
Walter J
Indian J Lepr; 1989 Jul; 61(3):379-86. PubMed ID: 2527921
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
6. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
8. A recessive major gene controls the mitsuda reaction in a region endemic for leprosy.
Ranque B; Alcais A; Thuc NV; Woynard S; Thai VH; Huong NT; Ba NN; Khoa PX; Schurr E; Abel L
J Infect Dis; 2005 Oct; 192(8):1475-82. PubMed ID: 16170767
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients].
Minagawa F; Yoshino Y; Abe M; Saito N; Ohsawa Y; Ozawa T; Saikawa K
Nihon Rai Gakkai Zasshi; 1989; 58(2):92-111. PubMed ID: 2697714
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
11. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
[TBL] [Abstract][Full Text] [Related]
12. Adenosine deaminase activity in leprosy.
Suri Babu SS; Kannan KB; Katoch VM; Bharadwaj VP
Indian J Lepr; 1990; 62(4):473-7. PubMed ID: 2086683
[TBL] [Abstract][Full Text] [Related]
13. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
[TBL] [Abstract][Full Text] [Related]
14. Effect of dapsone (DDS) on T-cells and their response to PHA and lepromin in tuberculoid leprosy patients.
Kumar B; Ganguly NK; Kaur S; Vaishnavi C; Chakravarti RN
Lepr India; 1983 Jul; 55(3):465-71. PubMed ID: 6606732
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
16. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
Convit J; Aranzazu N; Pinardi M; Ulrich M
Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
[TBL] [Abstract][Full Text] [Related]
18. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
[TBL] [Abstract][Full Text] [Related]
19. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
20. Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships.
Alcaïs A; Sanchez FO; Thuc NV; Lap VD; Oberti J; Lagrange PH; Schurr E; Abel L
J Infect Dis; 2000 Jan; 181(1):302-8. PubMed ID: 10608779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
